And when I find generic drugs that might have a value, I have never been able to get

any pharmaceutical industry interested in that, even though they could be potentially

life-saving.

It's just not economically feasible, and I'm not complaining about pharma, and I would never

do that.

It's just that that model doesn't work.

So de-risking the risk of making drugs across millions and possibly billions of people

in a decentralized funding could be absolutely revolutionary. Remember, 7,500 drugs are approved,

and we have no idea what they could be used for. And I believe they can be used for many things.

This episode is sponsored by Circle.

Money is changing. So where do we go from here? Through high profile interviews and thought

provoking analysis, join Michael Casey and Sheila Warren for the Money Reimagined podcast as they

explore the connection between finance, human

culture, and are increasingly digital lives.

And just a reminder, CoinDesk is a new source and does not provide investment advice.

And now, here's Michael Casey.

Hello and welcome to Money Reimagined.

I'm Michael Casey. I'm on my lonesome today. Sheila is out for a week.

We're talking about medicine today, specifically the role that decentralized organizations or DAOs can play in helping to lower the astronomical cost of drug development and to accelerate it.

I'm joined by Giannauro Dursa, the founder and chairman of genetic networks,

whose idea for something he's calling Farmer Dow is getting a lot of attention. It's a radical

new way of getting around the inefficiencies and monopolistic behavior of big pharma,

...